Merestinib
id:
merestinib-179-3491740
title:
Merestinib
text:
Merestinib (LY2801653) is an experimental cancer drug in development by Eli Lilly. It is a small molecule inhibitor of MET and several other receptor tyrosine kinases such as MST1R, FLT3, AXL, MERTK, TEK, ROS1, NTRK1/2/3, and DDR1/2. Meristinib is part of a phase II clinical trial for advanced billiary tract cancer. The study is expected to be complete in April 2018. Phase II clinical trials for non-small cell lung cancer and solid tumors began in November 2016.
brand slug:
wiki
category slug:
encyclopedia
description:
Experimental cancer drug
original url:
https://en.wikipedia.org/wiki/Merestinib
date created:
2017-01-10T21:44:41Z
date modified:
2024-09-04T21:06:34Z
main entity:
{"identifier":"Q27262653","url":"https://www.wikidata.org/entity/Q27262653"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/9/9d/Merestinib.svg","width":512,"height":246}
fields total:
13
integrity:
16